Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41390-020-1053-9 http://scihub22266oqcxt.onion/10.1038/s41390-020-1053-9 32634818!7577838!32634818     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Pediatr+Res 2020 ; 88 (5): 705-716 Nephropedia Template TP {{tp|p=32634818|t=2020. COVID-19 PICU guidelines: for high- and limited-resource settings |pdf=|usr=}}{{32634818}} gab.com Text COVID-19 PICU guidelines: for high- and limited-resource settings JO: Pediatr Res http://www.kidney.de/pget.php?&tw=1&pmid=32634818 #FOAvip BACKGROUND: Fewer children than adults have been affected by the COVID-19 pandemic, and the clinical manifestations are distinct from those of adults. Some children particularly those with acute or chronic co-morbidities are likely to develop critical illness. Recently, a multisystem inflammatory syndrome (MIS-C) has been described in children with some of these patients requiring care in the pediatric ICU. METHODS: An international collaboration was formed to review the available evidence and develop evidence-based guidelines for the care of critically ill children with SARS-CoV-2 infection. Where the evidence was lacking, those gaps were replaced with consensus-based guidelines. RESULTS: This process has generated 44 recommendations related to pediatric COVID-19 patients presenting with respiratory distress or failure, sepsis or septic shock, cardiopulmonary arrest, MIS-C, those requiring adjuvant therapies, or ECMO. Evidence to explain the milder disease patterns in children and the potential to use repurposed anti-viral drugs, anti-inflammatory or anti-thrombotic therapies are also described. CONCLUSION: Brief summaries of pediatric SARS-CoV-2 infection in different regions of the world are included since few registries are capturing this data globally. These guidelines seek to harmonize the standards and strategies for intensive care that critically ill children with COVID-19 receive across the world. IMPACT: At the time of publication, this is the latest evidence for managing critically ill children infected with SARS-CoV-2. Referring to these guidelines can decrease the morbidity and potentially the mortality of children effected by COVID-19 and its sequalae. These guidelines can be adapted to both high- and limited-resource settings. Twit Text FOAVip COVID-19 PICU guidelines: for high- and limited-resource settings ????Pediatr Res http://www.kidney.de/pget.php?&tw=1&pmid=32634818 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32634818 #FOAvip English Wikipedia <ref>{{Cite pmid|32634818}}</ref> COVID-19 PICU guidelines: for high- and limited-resource settings #MMPMID32634818 Kache S; Chisti MJ; Gumbo F; Mupere E; Zhi X; Nallasamy K; Nakagawa S; Lee JH; Di Nardo M; de la Oliva P; Katyal C; Anand KJS; de Souza DC; Lanziotti VS; Carcillo J Pediatr Res 2020[Nov]; 88 (5): 705-716 PMID32634818show ga BACKGROUND: Fewer children than adults have been affected by the COVID-19 pandemic, and the clinical manifestations are distinct from those of adults. Some children particularly those with acute or chronic co-morbidities are likely to develop critical illness. Recently, a multisystem inflammatory syndrome (MIS-C) has been described in children with some of these patients requiring care in the pediatric ICU. METHODS: An international collaboration was formed to review the available evidence and develop evidence-based guidelines for the care of critically ill children with SARS-CoV-2 infection. Where the evidence was lacking, those gaps were replaced with consensus-based guidelines. RESULTS: This process has generated 44 recommendations related to pediatric COVID-19 patients presenting with respiratory distress or failure, sepsis or septic shock, cardiopulmonary arrest, MIS-C, those requiring adjuvant therapies, or ECMO. Evidence to explain the milder disease patterns in children and the potential to use repurposed anti-viral drugs, anti-inflammatory or anti-thrombotic therapies are also described. CONCLUSION: Brief summaries of pediatric SARS-CoV-2 infection in different regions of the world are included since few registries are capturing this data globally. These guidelines seek to harmonize the standards and strategies for intensive care that critically ill children with COVID-19 receive across the world. IMPACT: At the time of publication, this is the latest evidence for managing critically ill children infected with SARS-CoV-2. Referring to these guidelines can decrease the morbidity and potentially the mortality of children effected by COVID-19 and its sequalae. These guidelines can be adapted to both high- and limited-resource settings. |*Betacoronavirus[MESH] |*Pandemics[MESH] |Adolescent[MESH] |Africa/epidemiology[MESH] |Americas/epidemiology[MESH] |Antiviral Agents/therapeutic use[MESH] |Asia/epidemiology[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Cardiopulmonary Resuscitation/methods/standards[MESH] |Child[MESH] |Child, Preschool[MESH] |Combined Modality Therapy[MESH] |Comorbidity[MESH] |Coronavirus Infections/complications/drug therapy/epidemiology/*therapy[MESH] |Critical Care/methods/*standards[MESH] |Cross Infection/prevention & control[MESH] |Europe/epidemiology[MESH] |Extracorporeal Membrane Oxygenation/standards[MESH] |Female[MESH] |Humans[MESH] |Infant[MESH] |Infant, Newborn[MESH] |Infection Control/methods/standards[MESH] |Intensive Care Units, Pediatric/*standards[MESH] |Male[MESH] |Pneumonia, Viral/complications/epidemiology/*therapy[MESH] |Respiration, Artificial/standards[MESH] |Respiratory Distress Syndrome/etiology/therapy[MESH] |SARS-CoV-2[MESH] |Shock/etiology/therapy[MESH]COVID-19 PICU guidelines: for high- and limited-resource settings (epmc).pdf DeepDyve Pubget Overpricing